These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2408528)

  • 1. Chronic lymphocytic leukemia. Recent advances in biology and treatment.
    Gale RP; Foon KA
    Ann Intern Med; 1985 Jul; 103(1):101-20. PubMed ID: 2408528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of chronic lymphocytic leukemia.
    Gale RP; Foon KA
    Semin Hematol; 1987 Oct; 24(4):209-29. PubMed ID: 3317850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging and therapy of chronic lymphocytic leukemia.
    Foon KA; Gale RP
    Semin Hematol; 1987 Oct; 24(4):264-74. PubMed ID: 2446394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic markers in childhood acute lymphocytic leukemia.
    Crist WM; Grossi CE; Pullen DJ; Cooper MD
    Semin Oncol; 1985 Jun; 12(2):105-21. PubMed ID: 3892693
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress in biology and treatment of chronic lymphocytic leukemia].
    Robak T
    Postepy Hig Med Dosw; 1988; 42(5):483-522. PubMed ID: 3076236
    [No Abstract]   [Full Text] [Related]  

  • 6. Relevance of surface markers in chronic lymphocytic leukemia to acute lymphocytic leukemia.
    Aisenberg AC; Wilkes BM
    Cancer Res; 1981 Nov; 41(11 Pt 2):4810-3. PubMed ID: 6975164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of immunotyping in chronic lymphocytosis: review of the natural history of the condition in 145 adult patients.
    Tefferi A; Li CY; Phyliky RL
    Mayo Clin Proc; 1988 Aug; 63(8):801-6. PubMed ID: 2456433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lymphocytic leukemia.
    Stahl RL; Silber R
    Clin Geriatr Med; 1985 Nov; 1(4):857-67. PubMed ID: 3830389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolymphocytic leukaemia.
    Catovsky D
    Nouv Rev Fr Hematol (1978); 1982; 24(6):343-7. PubMed ID: 6762526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic leukapheresis in a patient with prolymphocytic transformation of B-cell chronic lymphocytic leukemia.
    Steenssens L; Van Camp B
    Int J Artif Organs; 1984 May; 7(3):139-42. PubMed ID: 6610651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphoid leukemias: recent advances in biology and therapy.
    Foon KA
    Stem Cells; 1995 Jan; 13(1):1-21. PubMed ID: 7719244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influential T cell in B-cell neoplasms.
    Kay NE; Oken MM; Perri RT
    J Clin Oncol; 1983 Dec; 1(12):810-6. PubMed ID: 6230420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of helper activity for B-lymphocyte differentiation with lymphocytes having both SRBC and complement receptors in a patient with lymphoproliferative disease.
    Chiao JW; Pahwa S; Arlin ZA; Good RA
    Clin Immunol Immunopathol; 1979 Jun; 13(2):125-35. PubMed ID: 313300
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlations.
    Dillman RO; Beauregard JC; Lea JW; Green MR; Sobol RE; Royston I
    J Clin Oncol; 1983 Mar; 1(3):190-7. PubMed ID: 6607975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the treatment of chronic lymphocytic leukemia: defining the role of intravenous immunoglobulin.
    Besa EC
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):14-23. PubMed ID: 1380736
    [No Abstract]   [Full Text] [Related]  

  • 18. T-chronic lymphocytic leukaemia presenting as primary hypogammaglobulinaemia--evidence of a proliferation of T-suppressor cells.
    Thien SL; Catovsky D; Oscier D; Goldman JM; van der Reijden HJ; Melief CJ; Rümke HC; Ten Berge RJ; von dem Borne AE
    Clin Exp Immunol; 1982 Mar; 47(3):670-6. PubMed ID: 6211309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin gene rearrangements in hairy cell leukemia and other chronic B cell lymphoproliferative disorders.
    Foroni L; Catovsky D; Luzzatto L
    Leukemia; 1987 Apr; 1(4):389-92. PubMed ID: 3118109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukemia: new insights into biology and therapy.
    Foon KA; Rai KR; Gale RP
    Ann Intern Med; 1990 Oct; 113(7):525-39. PubMed ID: 2203293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.